Published in Pediatrics on December 01, 1972
Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49
Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol (2001) 2.72
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant (2010) 2.33
Pharmacokinetics of theophylline in children with asthma. Pediatrics (1976) 2.31
Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther (1974) 2.26
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin Pharmacol Ther (1972) 1.90
The changing natural history of spinal muscular atrophy type 1. Neurology (2007) 1.87
Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med (1966) 1.83
Pharmacokinetics of salicylate elimination in man. J Pharm Sci (1965) 1.78
Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol (1998) 1.77
Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet (1990) 1.76
Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med (1982) 1.73
Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther (1972) 1.70
Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation (1999) 1.67
Salicylate accumulation kinetics in man. N Engl J Med (1972) 1.65
Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther (1976) 1.63
Anonymous living liver donation: donor profiles and outcomes. Am J Transplant (2010) 1.60
Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab (1998) 1.59
Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology (1995) 1.56
Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics (1975) 1.52
Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther (1969) 1.50
Outcome of lower L-thyroxine dose for treatment of congenital hypothyroidism. Clin Pediatr (Phila) (1995) 1.50
Effect of an anticholinergic agent on riboflavin absorption in man. J Pharm Sci (1972) 1.49
Elevated threshold for thyrotropin suppression in congenital hypothyroidism. Am J Dis Child (1980) 1.48
Quality of life among formerly treated childhood-onset growth hormone-deficient adults: a comparison with unaffected siblings. J Clin Endocrinol Metab (1998) 1.45
An octopus-bioinspired solution to movement and manipulation for soft robots. Bioinspir Biomim (2011) 1.45
Potentiation of isoproterenol effect by ascorbic acid. Res Commun Chem Pathol Pharmacol (1976) 1.43
The ALSFRSr predicts survival time in an ALS clinic population. Neurology (2005) 1.42
Sex steroids do not influence somatic growth in childhood. Am J Dis Child (1989) 1.39
Effect of dietary protein intake on renal growth: possible role of insulin-like growth factor-I. J Lab Clin Med (1993) 1.39
Xenotransplantation. Can J Surg (1999) 1.39
Human myosin VIIA responsible for the Usher 1B syndrome: a predicted membrane-associated motor protein expressed in developing sensory epithelia. Proc Natl Acad Sci U S A (1996) 1.38
Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide. J Pharm Sci (1971) 1.35
Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin Pharmacol Ther (1969) 1.33
Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in newborns. Am J Dis Child (1970) 1.33
Human dicentric Y chromosomes. Case report and review of the literature. J Med Genet (1973) 1.32
Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum. J Med Virol (1996) 1.30
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology (2001) 1.29
Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man. J Pharm Sci (1968) 1.29
Drug biotransformation interactions in man VI: acetaminophen and ascorbic acid. J Pharm Sci (1976) 1.28
Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr (1975) 1.25
Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Ther (1967) 1.25
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther (1980) 1.20
Effect of activated charcoal on acetaminophen absorption. Pediatrics (1976) 1.17
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology (1999) 1.17
Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics (1974) 1.16
Effect of plasma protein and tissue binding on the biologic half-life of drugs. Clin Pharmacol Ther (1978) 1.16
Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med (1992) 1.15
Pharmacokinetics of salicylate in man. Drug Metab Rev (1979) 1.13
Evaluation of methods for producing renal dysfunction in rats. J Pharm Sci (1981) 1.13
Rashba spin-splitting control at the surface of the topological insulator Bi2Se3. Phys Rev Lett (2011) 1.11
Protein binding of warfarin enantiomers in serum of humans and rats. J Pharmacokinet Biopharm (1977) 1.11
Aspirin, absorption rate and analgesic effect. Anesth Analg (1966) 1.10
Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology (2003) 1.09
Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther (1976) 1.09
Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man. J Pharm Sci (1970) 1.09
Multicystic ovaries in primary hypothyroidism. Obstet Gynecol (1983) 1.07
Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. Clin Pharmacol Ther (1975) 1.07
Urine pH and salicylate therapy. JAMA (1971) 1.06
Lactate provocation of panic attacks. I. Clinical and behavioral findings. Arch Gen Psychiatry (1984) 1.06
Studies of growth hormone secretion in children: normal, hypopituitary and constitutionally delayed. J Clin Endocrinol Metab (1967) 1.06
Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults. Clin Pharmacol Ther (1977) 1.06
Familial 46,XX males coexisting with familial 46,XX true hermaphrodites in same pedigree. J Pediatr (1987) 1.05
Importance of assay specificity for plasma protein binding determinations. J Pharmacokinet Biopharm (1975) 1.05
Kinetics of pharmacologic effects. Clin Pharmacol Ther (1966) 1.05
Pharmacokinetics in renal disease. Am J Med (1977) 1.04
Pharmacokinetics of drug action. Annu Rev Pharmacol (1972) 1.04
Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation. Br J Clin Pharmacol (1979) 1.04
Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination. J Pharm Sci (1968) 1.03
Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther (1979) 1.03
Overexpression of poly(A)-binding protein down-regulates the translation or the abundance of its own mRNA. FEBS Lett (1999) 1.03
Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res (1988) 1.02
Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis (2000) 1.02
Influence of setting on unattended respiratory monitoring in the sleep apnoea/hypopnoea syndrome. Eur Respir J (2001) 1.01
Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations. Clin Pharmacol Ther (1978) 1.01
From front line to home front: a study of secondary traumatization. Fam Process (1992) 1.01
Letter: Effect of plasma protein binding on elimination of warfarin. J Pharm Sci (1974) 1.00
Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect. J Pharmacol Exp Ther (1984) 1.00
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl (2001) 0.99
The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem (1999) 0.99
Self-reported sleepiness while driving as a risk factor for traffic accidents in patients with obstructive sleep apnoea syndrome and in non-apnoeic snorers. Respir Med (2000) 0.99
Induction of macrophage procoagulant activity by Bacteroides fragilis. Infect Immun (1989) 0.99
Effect of antacids on pH of urine. Clin Pharmacol Ther (1974) 0.98
Decreased serum salicylate concentrations in children with rheumatic fever treated with antacid. N Engl J Med (1975) 0.98
Effect of polysorbate 80 and oleic acid on drug absorption from the rat intestine. J Pharm Sci (1970) 0.98
Pharmacokinetics of the warfarin enantiomers in rats. J Pharmacokinet Biopharm (1974) 0.98
Biopharmaceutical aspects of aspirin-induced gastrointestinal blood loss in man. J Pharm Sci (1969) 0.97
Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry (1996) 0.97
Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab (1970) 0.97
Ticrynafen effect on warfarin protein binding in human serum. J Pharm Sci (1979) 0.97
Clinical pharmacokinetics of aspirin. Pediatrics (1978) 0.97
Excitatory and inhibitory corticospinal responses to transcranial magnetic stimulation in patients with minor to moderate head injury. J Neurol Neurosurg Psychiatry (2001) 0.97
Polarity-driven surface metallicity in SmB6. Phys Rev Lett (2013) 0.97